Abstract Submission is open until March 9th!

Sub-Themes to explore

1) Going beyond health: Building Partnerships and Strengthening Collaboration for Health In All Policies 

Actionable case studies, frameworks, and strategies to build and maintain effective partnerships across actors to integrate health concerns addressed in evidence synthesis and guidelines in policies and practices of other sectors, such as environment, agriculture, and education, including at the intersection of human, animal, and environmental health are one of the main topics of this subtheme. The subtheme may include innovative, multi-sector global, regional, and local efforts to combat antimicrobial resistance and (re)emerging infectious and zoonotic diseases through effective and collaborative guidelines and policies.
As for all other subthemes, equity considerations are playing a critical role here.

2) Harnessing Artificial Intelligence, Technology and Digital Innovations in Guideline Development and Implementation 

Work that showcases use of artificial intelligence (AI), technological innovations in evidence synthesis and guideline development, adaptation or implementation aiming to improve equitable access, delivery, and quality of healthcare while improving efficiency and optimising the resource use. A particular topic of interest is how AI and technology increases accessibility of recommendations globally. Implementation of guideline recommendations requires interlinkages with the other elements of the systems that can benefit from machine supported solutions, e.g. accreditation program, insurance policies, quality improvement initiatives as well as the legal and professional responsibilities and mandates.

3) Innovative approaches to develop and scale up guidelines for better Planetary Health 

Advancements to address and consider the health dimensions of human-caused environmental change on a planetary scale. Potential topics include sustainable health systems, environmental resilience, ecosystem-based health interventions, innovations and implications of clinical and public health guidelines considering planetary health. In particular, there is increasing work done on considering planetary health in evidence synthesis for clinical and public health guidelines and development of guidelines related to climate change and public health. This theme would may include antimicrobial resistance and its relation to planetary health. 

4) Building Trust in Science and Transforming Health Systems through Guidelines 

Work demonstrating examples and potential of guidelines leading to more trust in health systems and governments from perspectives of patients, providers and policy makers as well as transformative changes and strategies in making health systems more equitable, responsive, resilient to crises like pandemics, climate change, and natural disasters.  

5) A Unified Framework for Health Decision-Making and Informing Research 

This subtheme focuses on creating a comprehensive, transdisciplinary framework for health decision-making including all the relevant actors that are often disconnected, where evidence synthesis methods and guidelines play a crucial link. Inspired by the idea of a “theory of everything in health decision-making,” this theme would aim to bridge gaps across disciplines, methodologies, and interest holder perspectives, integrating scientific evidence, values, ethics and contextual factors into a cohesive approach for making health decisions. Such examples include close linkage and alignment between guidelines, HTA, regulators and coverage decision-making programmes, but it is not limited to this. They also include aspects of monitoring and evaluation of health decisions as they are implemented, globally, nationally and locally. Another primary goal is to use the framework to identify research priorities from health to social sciences and policy making.   

Presentation Types

Long Oral: A spoken presentation, including introduction, question, and answer time. Presenters display the research and/or findings of their accepted abstract in a PowerPoint presentation. (10-minute presentation plus 5-minute Q&A).

Short Oral: A spoken presentation, including introduction, question, and answer time. Presenters display the research and/or findings of their accepted abstract in a PowerPoint presentation. (6-minute presentation plus 2-minute Q&A).

Poster: The Conference will dedicate an allotted time for poster presentations, with opportunity for audience participation and enquiry.

Workshop: Interactive workshops will be either 45 or 90 minutes long, and must be aligned with the Conference theme. Workshops can also be focused on problem-solving, where participants are split into groups to address difficult problems and then report back at the end of the workshop.

Panel sessions: Thematically jointly focused spoken presentation, including introduction, question, and answer time. Presenters display the research and/or findings of their accepted abstract in a PowerPoint presentation. (10 minute presentation plus 5 minute Q&A) up to 5 presenters.

Terms & Conditions

The submission of an abstract indicates an understanding of the following rules for participation in the conference.

  • All author(s) approve submitting this work for presentation.
  • The author(s) transfer(s) all copyright ownership of the named abstract to GIN 2025 Conference.
  • The author(s) agree(s) to materially confine their presentations to information in the abstract if accepted for presentation. If an author has more than one abstract accepted, each presentation will be materially confined to the information in the abstract selected for the authors about the status of the abstract.
  • Submission of the abstract constitutes consent of all authors of the abstract to publication (e.g, GIN website, programs and other promotions).
  • All authors of the abstract warrant and represent that they either are the sole owners of or have all necessary rights to sublicense all the information and content in the abstract provided to GIN and its organisers, and that publication of the abstract does not infringe any rights, including but not limited to, intellectual property rights, or of any third parties.
  • GIN 2025 reserves the right to remove from any publication any abstract that does not comply with the above.

Please contact gin2025@g-i-n.net for any queries.